AS-8351 is primarily utilized in the field of biomedical research, particularly in studies focusing on cancer therapy. It functions as a selective inhibitor targeting specific enzymes or proteins involved in tumor growth and proliferation. Researchers employ AS-8351 to investigate its potential in disrupting signaling pathways that are crucial for cancer cell survival. This makes it a valuable tool for understanding the mechanisms of cancer and developing targeted therapeutic strategies. Additionally, it is used in preclinical studies to evaluate its efficacy and safety profile in animal models, paving the way for potential clinical applications in oncology.